Harrow, Inc. (NASDAQ:HROW - Get Free Report) shares were down 4.6% during trading on Wednesday . The company traded as low as $25.17 and last traded at $25.74. Approximately 93,816 shares changed hands during trading, a decline of 81% from the average daily volume of 501,370 shares. The stock had previously closed at $26.98.
Wall Street Analyst Weigh In
Several analysts have recently commented on the company. HC Wainwright reissued a "buy" rating and issued a $57.00 price objective on shares of Harrow in a research note on Tuesday, March 18th. B. Riley lowered their price target on Harrow from $73.00 to $69.00 and set a "buy" rating for the company in a research report on Wednesday, December 4th.
View Our Latest Report on Harrow
Harrow Stock Performance
The company's 50 day simple moving average is $29.51 and its 200 day simple moving average is $38.38. The company has a debt-to-equity ratio of 3.23, a quick ratio of 1.44 and a current ratio of 1.55. The stock has a market cap of $1.01 billion, a PE ratio of -30.22 and a beta of 0.69.
Institutional Trading of Harrow
A number of institutional investors and hedge funds have recently modified their holdings of HROW. Woodmont Investment Counsel LLC boosted its position in Harrow by 0.5% in the fourth quarter. Woodmont Investment Counsel LLC now owns 81,400 shares of the company's stock worth $2,731,000 after purchasing an additional 445 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Harrow by 3.5% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,356 shares of the company's stock worth $582,000 after purchasing an additional 585 shares during the period. Swiss National Bank boosted its holdings in shares of Harrow by 1.0% in the 4th quarter. Swiss National Bank now owns 59,300 shares of the company's stock worth $1,990,000 after buying an additional 600 shares during the last quarter. Quest Partners LLC bought a new position in Harrow during the third quarter valued at about $29,000. Finally, China Universal Asset Management Co. Ltd. increased its holdings in Harrow by 10.7% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 7,552 shares of the company's stock worth $253,000 after buying an additional 727 shares during the last quarter. 72.76% of the stock is owned by hedge funds and other institutional investors.
About Harrow
(
Get Free Report)
Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.
See Also
Before you consider Harrow, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Harrow wasn't on the list.
While Harrow currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
